Skip to main content

and
  1. Article

    Open Access

    Mitochondria-DNA copy-number and incident venous thromboembolism among middle-aged women: a population-based cohort study

    Venous thromboembolism (VTE) is the third most common cardiovascular disease. Low amount of mitochondrial DNA copy number (mtDNA-CN) has been associated with arterial cardiovascular disease (CVD) and reflects ...

    Peter Nymberg, Ashfaque A. Memon, Jan Sundquist in Journal of Thrombosis and Thrombolysis (2021)

  2. Article

    Open Access

    Risk prediction of recurrent venous thromboembolism: a multiple genetic risk model

    A single genetic biomarker is unable to accurately predict the risk for venous thromboembolism (VTE) recurrence. We aimed to: (a) develop a multiple single nucleotide polymorphisms (SNPs) model to predict the ...

    Abrar Ahmad, Kristina Sundquist, Karolina Palmér in Journal of Thrombosis and Thrombolysis (2019)

  3. Article

    Open Access

    Polymorphisms in PARK2 and MRPL37 are associated with higher risk of recurrent venous thromboembolism in a sex-specific manner

    Recent studies indicate that mitochondrial DNA (mtDNA) dysfunction is a biomarker of oxidative stress and can predict the risk of cardiovascular diseases (CVDs). Genetic variants in PARK2 (rs4708928) and MRPL37 (...

    Kristina Sundquist, Abrar Ahmad in Journal of Thrombosis and Thrombolysis (2018)

  4. Article

    Open Access

    Association between TLR9 rs5743836 polymorphism and risk of recurrent venous thromboembolism

    Recent gene knockout studies on mice have shown the role of toll-like receptor 9 (TLR9) in resolution of venous thromboembolism (VTE) through sterile inflammation. However, the role of a putative functional TLR9 ...

    Abrar Ahmad, Kristina Sundquist, Bengt Zöller in Journal of Thrombosis and Thrombolysis (2017)

  5. No Access

    Article

    Thrombomodulin gene c.1418C>T polymorphism and risk of recurrent venous thromboembolism

    Thrombomodulin gene (THBD) is a critical cofactor in protein C anticoagulant system. THBD c.1418C>T polymorphism is reported to be associated with higher risk of primary venous thromboembolism (VTE) but its ro...

    Abrar Ahmad, Kristina Sundquist, Bengt Zöller in Journal of Thrombosis and Thrombolysis (2016)

  6. Article

    Open Access

    Palaeolithic diet decreases fasting plasma leptin concentrations more than a diabetes diet in patients with type 2 diabetes: a randomised cross-over trial

    We have previously shown that a Palaeolithic diet consisting of the typical food groups that our ancestors ate during the Palaeolithic era, improves cardiovascular disease risk factors and glucose control comp...

    Maelán Fontes-Villalba, Staffan Lindeberg, Yvonne Granfeldt in Cardiovascular Diabetology (2016)

  7. Article

    Open Access

    Yoga’s effect on inflammatory biomarkers and metabolic risk factors in a high risk population – a controlled trial in primary care

    Yoga can reduce blood pressure and has also been suggested to reduce inflammatory biomarkers and metabolic risk factors for cardiovascular diseases (CVDs). We aimed to assess the benefit of two yoga interventi...

    Moa Wolff, Ashfaque A. Memon, John P. Chalmers in BMC Cardiovascular Disorders (2015)

  8. No Access

    Article

    Transforming growth factor (TGF)-β levels and unprovoked recurrent venous thromboembolism

    Prediction of recurrence in patients with unprovoked venous thromboembolism (VTE) remains a challenge. Studies of atherosclerosis suggest a protective role of transforming growth factor (TGF)-β. However, the r...

    Ashfaque A. Memon, Kristina Sundquist, **ao Wang in Journal of Thrombosis and Thrombolysis (2014)